Improvement of chronic osteomyelitis after granulocyte colony stimulating factor
- PMID: 24426334
- PMCID: PMC3572250
- DOI: 10.1007/s12288-011-0127-6
Improvement of chronic osteomyelitis after granulocyte colony stimulating factor
Abstract
Background: chronic osteomyelitis represents a persistent bone and bone marrow infection easy to diagnose in the presence of pain, erythema, swelling, and a draining sinus but more difficult to detect in the absence of the preceding features and with a painful orthopaedic prosthesis.
Case description: we report upon an elderly gentleman with myelodysplasia requiring revision surgery for a fractured prosthetic left knee. He had clinical, laboratory, and radiological features of chronic osteomyelitis that improved only with administration of granulocyte colony stimulating factor (G-CSF).
Literature review: G-CSF has been successfully employed to treat resistant osteomyelitis in three young patients with primary defects of monocyte and neutrophil killing. A randomized trial confirmed the efficacy of G-CSF in the treatment of chronic osteomyelitis in twenty patients with diabetic foot ulcers and a rat model confirmed the efficacy of G-CSF in acute osteomyelitis.
Clinical relevance: our case highlights the usefulness of G-CSF treatment for immune suppressed patients with resistant chronic osteomyelitis.
Figures
References
-
- Carulli G. Effects of recombinant human granulocyte colony-stimulating factors administration on neutrophil phenotype and functions. Haematologica. 1997;82:606–616. - PubMed
-
- de Lalla F, Pellizzer G, Strazzabosco M, Martini Z, Du Jardin G, Lora L, Fabris P, Benedetti P, Erle G. Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection. Antimicrob Agents Chemother. 2001;45:1094–1098. doi: 10.1128/AAC.45.4.1094-1098.2001. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources